research Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
This study found that sorafenib was active against desmoid tumors, with 25% of patients achieving a partial response and 70% maintaining stable disease.


São Paulo, SP, Brazil
Indonesia
Ahmedabad, Gujarat, India
Pimpri-Chinchwad, Maharashtra, India
Surat, Gujarat, India
Sāngli, Maharashtra, India